SCHEMBL31667547

SCHEMBL31667547

COc1nc2cc(CN3C(=O)c4ccccc4C3Cc3ncccc3Br)ccc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.38
WDR77 Q9BQA1 3/20 0.38
KDM4E B2RXH2 6/20 0.36
HKDC1 Q2TB90 1/20 0.36
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 3/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPT P10636 3/20 0.33
ALOX15 P16050 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GLA P06280 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.32
CYP1B1 Q16678 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667686 0.89 PRMT5 (0.39) PRMT5WDR77KDM4EHKDC1ALDH1A1
SCHEMBL31667336 0.87 PRMT5 (0.41) PRMT5WDR77KDM4EHKDC1ALDH1A1
SCHEMBL31667733 0.87 PRMT5 (0.39) PRMT5WDR77ALDH1A1GAAHTT
SCHEMBL31667719 0.86 PRMT5 (0.38) PRMT5WDR77KDM4EALDH1A1HSD17B10
SCHEMBL31667066 0.83 PRMT5 (0.39) PRMT5WDR77KDM4EALDH1A1GAA
SCHEMBL31667465 0.82 PRMT5 (0.37) PRMT5WDR77KDM4EALDH1A1GAA
SCHEMBL31667575 0.81 KDM4E (0.54) KDM4EHKDC1ALDH1A1HSD17B10MAPT
SCHEMBL31667407 0.81 PRMT5 (0.36) PRMT5WDR77KDM4EALDH1A1GAA
SCHEMBL31667111 0.81 RAF1 (0.37) PRMT5WDR77ALDH1A1GAAHTT
SCHEMBL31667048 0.79 KDM4E (0.40) KDM4EHKDC1ALDH1A1HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 PRMT5 981/4885WDR77 2686/4885KDM4E 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.